West-Ward Sodium Ferric Glucosate Injection Recall: Subpotent Iron Content
West-Ward Pharmaceuticals recalls sodium ferric glucosate injection due to subpotent iron content found during stability testing. This may not deliver the intended dose. Contact for return instructions.
Lower-risk recall
Subpotent Drug: Product has an an out of specification in iron assay analysis found during 18 month stability testing.
Contact the company
What happened, in plain English
West-Ward Pharmaceuticals is recalling sodium ferric glucosate injection vials because the product has lower-than-stated iron content. This means the medication may not provide the intended dose to patients needing iron treatment. Read more at govinfonow.com/recall/42184-west-ward-sodium-ferric-glucosate-injection-recall-subpotent-iron-content.
Source Summary by GovInfoNow · govinfonow.com/recall/42184-west-ward-sodium-ferric-glucosate-injection-recall-subpotent-iron-content · Updated October 8, 2026 · FDA enforcement record: FDA #D-0172-2017
Cite this page
“West-Ward Sodium Ferric Glucosate Injection Recall: Subpotent Iron Content.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42184-west-ward-sodium-ferric-glucosate-injection-recall-subpotent-iron-content. Based on FDA recall #D-0172-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0172-2017%22&limit=1).
Why it’s dangerous
The product was found to have lower iron content than specified during 18-month stability testing. This could mean the medication does not deliver the intended dose to patients needing iron treatment.
Who’s affected
Patients prescribed this injection for iron deficiency are affected. Those using the product as directed for medical treatment are most at risk.
How to tell if you have this one
Check for vials labeled 'SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE INJECTION, 62.5mg elemental iron/5mL, 10 (5mL vials) per shelf pack'. The product was manufactured by Hikma Farmaceutica in Portugal and distributed by West-Ward in New Jersey.
- Brand
West-Ward Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Label
Look for the product name and NDC code 0143-9570-10 on the vial packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “US nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0172-2017 (November 17, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0172-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.